Basic Information | Post buying leads | Suppliers |
Name |
Nalorphine hydrochloride |
EINECS | N/A |
CAS No. | 57-29-4 | Density | g/cm3 |
PSA | 52.93000 | LogP | 2.49420 |
Solubility | N/A | Melting Point |
260-263° |
Formula | C19H21NO3•ClH | Boiling Point | 493.6°Cat760mmHg |
Molecular Weight | 347.87 | Flash Point | 252.3°C |
Transport Information | N/A | Appearance | N/A |
Safety | Poison by intravenous route. Moderately toxic by ingestion, subcutaneous, and intraperitoneal routes. Human systemic effects by intravenous route: euphoria, hallucinations and distorted perceptions, and toxic psychosis. Experimental reproductive effects. Caution: Violent withdrawal symptoms may occur in narcotic addicts. When heated to decomposition it emits very toxic fumes of NOx and HCl. See also (−)-MORPHINE. | Risk Codes | 22-39/23/24/25-23/24/25-11 |
Molecular Structure | Hazard Symbols | 3 | |
Synonyms |
nalorphinehydrochloride |
Molecule structure of Nalorphine hydrochloride (CAS NO.57-29-4):
Molecular Weight: 347.83588 g/mol
Molecular Formula: C19H22ClNO3
Boiling Point: 493.6 °C at 760 mmHg
Flash Point: 252.3 °C
Enthalpy of Vaporization: 80.13 kJ/mol
Vapour Pressure: 1.46E-10 mmHg at 25 °C
H-Bond Donor: 3
H-Bond Acceptor: 4
Rotatable Bond Count: 2
Tautomer Count: 3
Exact Mass: 347.128821
MonoIsotopic Mass: 347.128821
Topological Polar Surface Area: 52.9
Heavy Atom Count: 24
Complexity: 549
Defined Atom StereoCenter Count: 5
Canonical SMILES: C=CCN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O.Cl
Isomeric SMILES: C=CCN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O.Cl
InChI: InChI=1S/C19H21NO3.ClH/c1-2-8-20-9-7-19-12-4-6-15(22)18(19)23-17-14(21)5-3-11(16(17)19)10-13(12)20;/h2-6,12-13,15,18,21-22H,1,7-10H2;1H/t12-,13+,15-,18-,19-;/m0./s1
InChIKey: NAHATSPWSULUAA-ZQGPYOJVSA-N
EINECS of Nalorphine hydrochloride (CAS NO.57-29-4): 200-321-8
1. | ivn-hmn TDLo:143 µg/kg:CNS | AJPSAO American Journal of Psychiatry. 113 (1957),887. | ||
2. | orl-rat LD50:1150 mg/kg | AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. 123 (1959),48. | ||
3. | scu-rat LD50:1460 mg/kg | TXAPA9 Toxicology and Applied Pharmacology. 18 (1971),185. | ||
4. | ipr-mus LD50:447 mg/kg | AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. 103 (1955),489. | ||
5. | scu-mus LD50:670 mg/kg CLDND* | |||
6. | ivn-dog LD50:120 mg/kg | AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. 149 (1964),571. |
Poison by intravenous route. Moderately toxic by ingestion, subcutaneous, and intraperitoneal routes. Human systemic effects by intravenous route: euphoria, hallucinations and distorted perceptions, and toxic psychosis. Experimental reproductive effects. Caution: Violent withdrawal symptoms may occur in narcotic addicts. When heated to decomposition it emits very toxic fumes of NOx and HCl. See also (−)-MORPHINE.
Nalorphine hydrochloride (CAS NO.57-29-4) is also named as 17-Allyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6alpha-diol hydrochloride ; Allylmorphine hydrochloride ; Lethidrone ; Miromorfalil ; N-Allyl-2,12-dihydroxy-1,11-epoxymorphinene-13 hydrochloride ; N-Allylnormorphine hydrochloride ; Nalline ; Nalorphine HCl ; Normorphine, N-allyl-, hydrochloride ; UNII-9FPE56Z2TW ; Morphinan-3,6-alpha-diol, 17-allyl-7,8-didehydro-4,5-alpha-epoxy-, hydrochloride ; Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-(2-propenyl)-(5alpha,6alpha)-, hydrochloride .